Health New Zealand backtracks on Keytruda delay, will allow early access to some patients

a vile of Keytruda

6 Aug 2024

NZ Herald

Health New Zealand Te Whatu Ora has backed down on a plan to delay free access to a life-extending cancer drug after a backlash by patients and advocates.

Chief clinical officer Richard Sullivan said today that Health New Zealand would allow a small group of cancer patients to get early access to the medication Keytruda before Pharmac begins funding it later this year.

The Government is set to fund pembrolizumab, or Keytruda, for five more cancers: head and neck, triple negative breast cancer, colorectal cancer, bladder cancer and Hodgkin lymphoma – which can cost around $100,000 when unfunded.

Read more

Other stories

CommentaryCommentaryEquityLatestLatestTe Tiriti
The hīkoi (march) to protest NZ’s Treaty Principles Bill crosses Auckland Harbour Bridge
Treaties, truth and equality: how NZ, Australia and Canada are all struggling with colonial politics

Treaties, truth and equality: how NZ, Australia and Canada are all struggling with colonial politics

With the ACT Party’s Principles of the Treaty of Waitangi Bill having its first reading in parliament last week, the debate and protests have been – understandably – focused on the local historical and political landscape.

Academic Literature
Key elements and contextual factors that influence successful implementation of large-system transformation initiatives in the New Zealand health system: a realist evaluation

Key elements and contextual factors that influence successful implementation of large-system transformation initiatives in the New Zealand health system: a realist evaluation

Despite three decades of policy initiatives to improve integration of health care, delivery of health care in New Zealand remains fragmented, and health inequities persist for Māori and other high priority populations. Read...

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.